AR114693A1 - VACCINES AGAINST INTRAABDOMINAL INFECTIONS - Google Patents

VACCINES AGAINST INTRAABDOMINAL INFECTIONS

Info

Publication number
AR114693A1
AR114693A1 ARP190100615A ARP190100615A AR114693A1 AR 114693 A1 AR114693 A1 AR 114693A1 AR P190100615 A ARP190100615 A AR P190100615A AR P190100615 A ARP190100615 A AR P190100615A AR 114693 A1 AR114693 A1 AR 114693A1
Authority
AR
Argentina
Prior art keywords
vaccines against
intraabdominal infections
coli
compositions
intraabdominal
Prior art date
Application number
ARP190100615A
Other languages
Spanish (es)
Inventor
Jan Theunis Poolman
Original Assignee
Janssen Pharmaceuticals Inc
Janssen Vaccines & Prevention Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceuticals Inc, Janssen Vaccines & Prevention Bv filed Critical Janssen Pharmaceuticals Inc
Publication of AR114693A1 publication Critical patent/AR114693A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0258—Escherichia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55577—Saponins; Quil A; QS21; ISCOMS
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Composiciones y métodos para vacunar contra infecciones intraabdominales provocadas por E. coli. Las composiciones comprenden un polipéptido FimH, uno o más conjugados que comprenden polisacárido de antígenos de E. coli unidos en forma covalente a una proteína transportadora y un adyuvante.Compositions and methods for vaccinating against intra-abdominal infections caused by E. coli. The compositions comprise a FimH polypeptide, one or more conjugates comprising polysaccharide from E. coli antigens covalently linked to a carrier protein, and an adjuvant.

ARP190100615A 2018-03-12 2019-03-12 VACCINES AGAINST INTRAABDOMINAL INFECTIONS AR114693A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP18161252 2018-03-12

Publications (1)

Publication Number Publication Date
AR114693A1 true AR114693A1 (en) 2020-10-07

Family

ID=61832242

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP190100615A AR114693A1 (en) 2018-03-12 2019-03-12 VACCINES AGAINST INTRAABDOMINAL INFECTIONS

Country Status (1)

Country Link
AR (1) AR114693A1 (en)

Similar Documents

Publication Publication Date Title
CO2018010458A2 (en) Anti-tim-3 antibodies and compositions
PE20190207A1 (en) COMPOSITIONS INCLUDING BACTERIAL STRAINS
CY1121535T1 (en) USPA2 PROTEIN PRODUCTS AND THEIR USES
AR105470A1 (en) METHODS TO INDUCE AN IMMUNE RESPONSE
BR112016016580A2 (en) CAPSULAR POLYSACCHARIDES FROM STREPTOCOCCUS PNEUMONIAE AND CONJUGATES THEREOF
EA201691478A1 (en) NEW POLYSACCHARIDE AND ITS APPLICATIONS
EA201790294A1 (en) FLAGELLIN BASED MEANS AND APPLICATIONS INCLUDING EFFECTIVE VACCINATION
MX2016012124A (en) Antibodies against immunogenic glycopeptides, composition comprising the same and use thereof.
BR112017001588A2 (en) cdh6 antibody / drug conjugates
BR112016025291A2 (en) anti-ptk7-drug antibody conjugates
CL2016002667A1 (en) Novel anti-rnf43 antibodies and methods for use
CO2021004456A2 (en) Multivalent pneumococcal vaccines
EA201000903A1 (en) ANTITEL TO PCRV-ANTIGEN PSEUDOMONAS AERUGINOSA
BR112017011478A2 (en) antibody-antibiotic conjugate compound, antibody-antibiotic conjugate, pharmaceutical composition, methods of treating a bacterial infection and exterminating staph aureus, process for compound preparation, kit and antibiotic-binder intermediate
MX2020004543A (en) Zika vaccines and immunogenic compositions, and methods of using the same.
MX2019004690A (en) Antibody constructs.
CO2019003949A2 (en) Expec glycoconjugate vaccine formulations
EA202091690A1 (en) IMMUNOGENIC COMPOSITION CONTAINING STAPHYLOCOCCAL ANTIGENS
PE20211095A1 (en) ESCHERICHIA COLI COMPOSITIONS AND METHODS OF THEM
CL2011000877A1 (en) Immunogenic composition for the treatment and / or prophylaxis of cattle against microbiological infections because it comprises mycoplasma bovis antigen; method of co-administration of two or more antigens to cattle.
CL2021000855A1 (en) Alphavirus-based replicons for the delivery of biotherapies.
EA201990451A1 (en) COMPOSITION OF MULTI-VALENT PNEUMO-COCK CAPSULE POLYSACCHARIDE COMPOUNDS WITH PROTEIN-CARRIER AND ITS APPLICATION
BR112017005272A2 (en) cysteamine to treat yeast / mold infections
EA201591808A1 (en) COMPOSITIONS AND METHODS OF TREATMENT OF FUNGAL AND BACTERIAL PATHOGENS
BR112016015078A2 (en) method for preventing or treating h7n9 influenza virus infection, antibody use and pharmaceutical composition

Legal Events

Date Code Title Description
FB Suspension of granting procedure